The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I).
申请公布号
WO2011158044(A3)
申请公布日期
2012.02.23
申请号
WO2011GB51141
申请日期
2011.06.17
申请人
RESPIVERT LIMITED;MURRAY, PETER, JOHN;ONIONS, STUART, THOMAS;WILLIAMS, JONATHAN, GARETH;JOLY, KEVIN
发明人
MURRAY, PETER, JOHN;ONIONS, STUART, THOMAS;WILLIAMS, JONATHAN, GARETH;JOLY, KEVIN